Healthy Returns: Why people quit weight loss, diabetes drugs within one year
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
Wisconsin couple sues Walgreens and Optum Rx, saying son died after $500 price rise for asthma meds
A Wisconsin couple is suing Walgreens and a pharmacy benefits management company, alleging that their son died because he couldn't afford a sudden $500 spike in his asthma medication.
Daily Mail3d
Losing weight on fat jabs like Mounjaro or Ozempic? Here's how you keep it off for good... Follow these 6 steps to make sure you don't put the kilos straight back on once you ...
With weight loss drugs such as Ozempic and Mounjaro seemingly able to melt the pounds away, you might well think you'll never need a 'diet plan' again. Alas, you'd be wrong. As a leading weight ...
Futurism on MSN3d
Pharmacists Warn That People With Eating Disorders Are Misusing Wegovy Prescriptions
More and more people are taking weight loss injectables like Wegovy — but not everyone prescribed these drugs should have ...
Becker's Hospital Review5d
Mounjaro could replace painful daily treatment for rare disorder
Tirzepatide, the active ingredient in Eli Lilly's diabetes drug Mounjaro, may be an effective alternative to painful daily treatment for a rare disorder, according to research published Jan. 29 in ...
Top Medical Stocks To Consider – February 02nd
UnitedHealth Group, AbbVie, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks refer to equities in companies that are ...
Yahoo Style UK2d
What to know before considering weight loss jabs, as patients face further checks
Demand for weight loss jabs continues to surge, particularly as the NHS began offering Wegovy in late 2023 and will start offering Mounjaro to patients in March 2025. They have also become ...
pharmaphorum5d
Britain will be first to get new Mounjaro device, says Lilly
Eli Lilly is just weeks away from launching Mounjaro in the UK, after getting approval from medicines regulator, the MHRA, for a new formulation of the drug as a treatment for diabetes and obesity.